drugset / Trial / NCT01784133

A Twelve Week Safety and Efficacy Study in Rosacea

NCT01784133

Phase 2 Completed 240 enrolled Maruho Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate th safety and efficacy of one-daily topical application of CLS001 low, mid and high dose compared to vehicle gel in subjects with papulopustular rosacea.

Timeline

Start
2013-03
Primary completion
2014-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Omiganan Protein / enzyme biologic Topical

Indications